Results 131 to 140 of about 1,084,654 (294)
Vasodilatator Beta Blockers in Cardiovascular Disease
Beta adrenergic agonists (beta-blockers) have proven effects in cardiovascular area. However, their usage as first-line treatment had started to be questioned recently due to their side effects, mainly systemic hypertension.
core
Beta-adrenoblockers in cardiology practice
This article is focused on actual and disputable points of use of beta-blockers for decrease of cardiovascular events in patients with arterial hypertension, ischemic heart disease, heart failure, diabetes mellitus and after non-cardiac surgical ...
A. A. Garganeeva
doaj
Biophysical characterisation shows that NanX, a membrane transport protein from the major facilitator superfamily (MFS), forms both monomers and dimers after purification. AlphaFold modelling and substrate docking provide information on residues likely involved in substrate recognition for NanX and another MFS member, NanT.
Michael C. Newton‐Vesty +13 more
wiley +1 more source
The presence of biotin‐binding avidin proteins in fish and their biological significance are poorly characterized. We cataloged fish avidins and demonstrate that they are widely present and evolutionarily conserved. We created avd knockout zebrafish and show that zebavidin is dispensable for development and that resistance of avd knockout embryos in ...
Anni K. Saralahti +5 more
wiley +1 more source
Letter to Editor - Bradycardia Associated with Ophthalmic Beta-Blockers
The systemic adverse effects of ophthalmic beta-blockers including bradycardia may be overlooked. Beta-blockade can be highly hazardous to aged patients suffering from cardio-pulmonary diseases.1 This communication describes two patients with bradycardia
Calvo-Romero JM, Lima-Rodr\uedguez EM
core
The neurokinin 1 receptor exists as full‐length (NK1L) and C‐terminally truncated (NK1S) splice variants. We show that NK1S heterodimerizes with NK1L, impairing Gαq coupling and Ca2+ mobilization while enhancing β‐arrestin1 recruitment. NK1S suppresses substance P‐driven gene expression and cell migration, revealing NK1S as an endogenous biased ...
Lan Phuong Nguyen +8 more
wiley +1 more source
The Evaluation of Perioperative Beta-Blockers
Surgical patients on chronic beta-blocker therapy must continue to receive beta-blockers during the perioperative period. Failure to comply with this Joint Commission mandate can result in decrease reimbursements from the Centers for Medicare and ...
Polius-McLean, Marian.
core
The C‐terminal domain of yeast Arginyltransferase1 is essential for its catalytic activity
Arginyltransferase 1 (Ate1), a eukaryotic enzyme, catalyses arginylation, transferring arginine from tRNA‐Arg to the amino terminus of the target protein. Overexpression of Ate1 in yeast is lethal and is dependent on arginylation. This study elucidates how mutations in the cofactor‐binding and active site of Ate1 and truncation of its structural ...
Vikas Kumar Yadav +4 more
wiley +1 more source
Type I interferons modulate autophagy to shape gemcitabine response in pancreatic cancer cells
Type I interferons differentially modulate autophagy and the response of pancreatic cancer cells to gemcitabine. IFNα2b stimulates autophagic flux and protects cells from gemcitabine‐induced cell death, contributing to chemoresistance. In contrast, IFNβ1a inhibits autophagosome formation and enhances gemcitabine‐induced cell death, resulting in ...
Lucy E. Bonilla +10 more
wiley +1 more source
Neel, Prabha +2 more
openaire +2 more sources

